CAS: 59278-00-1; (2-Acetoxyethoxy)Methyl Acetate

该化合物是一种多功能酯化合物,其特点是双功能结构,既结合了醚又结合了乙酸酯组.该化学品因其作为有机合成中反应性中间体的作用而备受重视,特别是在聚合物,增塑剂和特殊化学品的生产中.其双乙酸能增强溶性和反应性,使其适合需要受控的酯化或转入工艺的应用.该化合物在中度条件下的稳定性,与一系列试剂的兼容性,进一步增强了其在精细化学制造中的效用.其平衡性使得研究人员和工业化学家在寻求高效合成途径时成为了实际的选择.

结构式图片

相似化合物

628-68-2 111-21-7 111-55-7

欧盟法规

REACH注册ECHA物质C&L通报REACH预注册

上下游产品

1,3-DIOXOLANE acetic anhydride Acetyl bromide sulfuric acid -5-fluorouracil1-(2-acetoxyethoxy)methyl-5-fluorouracil thiazine-7(1H)-thione1-(2-Acetoxyethoxymethyl)-5-phenylimidazo4,5-d1,3thiazine-7(1H)-thione thiazine-7(3H)-thione3-(2-Acetoxyethoxymethyl)-5-phenylimidazo4,5-d1,3thiazine-7(3H)-thione thiazine-7(3H)-thione3-(2-Acetoxyethoxymethyl)-5-benzylaminoimidazo4,5-d1,3thiazine-7(3H)-thione

合成工艺路线路线简述

    1,3-二氧戊环,乙酸酐置于硫酸,溶剂黄146体系中,化学反应生成 阿昔洛韦侧链
    参考文献:Synthesis Of Oligoribonucleotides Containing Pyrimidine 2'-O-[(Hydroxyalkoxy)Methyl]Ribonucleosides
    标题:Synthesis Of Oligoribonucleotides Containing Pyrimidine 2'-O-[(Hydroxyalkoxy)Methyl]Ribonucleosides
    摘要:一种制备嘧啶2'-O-[(2-羟乙氧基)甲基]核苷和2'-O-[(3-羟基丙氧基)甲基]核苷的简单高效方法已经开发出来.这些修饰的核苷被合并到寡核苷酸中,这些寡核苷酸被证明能形成稳定的rna/rna双链.
    DOI:10.1135/cccc20060804

    海关参考信息

    专利信息


    专利号:US-7078524-B2
    优先权日:2002-11-22
    标题:Process for the synthesis of ganciclovir
    发明人:BABU JAYACHANDRA SURESH; RAY PURNA CHANDRA; KUMAR YATENDRA; KHANDURI CHANDRA HAS
    权利人:RANBAXY LAB LTD
    摘要:The present invention relates to an industrial useful process for the synthesis of antiviral compound, ganciclovir which comprises dissolving a mixture containing N-7 and N-9 isomers of structural formulae, II and III, respectively: n n nin a solvent or a mixture of solvents; separating the N-7 and N-9 isomers; and hydrolizing the N-9 isomer to obtain ganciclovir.

    专利号:EP-1565469-A1
    优先权日:2002-11-22
    标题:Process for the synthesis of ganciclovir
    发明人:BABU JAYACHANDRA SURESH; RAY PURNA CHANDRA; KUMAR YATENDRA; KHANDURI CHANDRA HAS
    权利人:RANBAXY LAB LTD
    摘要:The present invention relates to an industrial useful process for the synthesis of antiviral compound, ganciclovir.

    专利号:WO-9724357-A1
    优先权日:1995-12-28
    标题 :Process for synthesis and purification of a compound useful in the preparation of acyclovir
    发明人:BUEHLER HENRY J; CASKEY DOUGLAS C
    权利人:MALLINCKRODT CHEMICAL INC; BUEHLER HENRY J; CASKEY DOUGLAS C
    摘要:Intermediate chemical compounds useful in the preparation of acyclovir and a method of synthesizing and purifying the intermediate chemical compounds. Diacetyl-guanine is alkylated and the resulting product washed with an alcohol to produce a relatively pure, crystalline diacetyl-acyclovir (DA-ACV). The diacetyl-acyclovir (DA-ACV) is hydrolyzed in the presence of potassium hydroxide to a novel potassium salt of acyclovir, acyclovir potassium enolate. The acyclovir potassium salt is converted into essentially pure acyclovir. The step of hydrolyzing diacetyl-acyclovir and forming the potassium salt occurs simultaneously. The potassium salt of acyclovir is converted to acyclovir by dissolving in water in the presence of an acid to generate an essentially pure acyclovir. The resulting acyclovir normally needs no further purification and meets the specification of U.S.P. XXIII. Thus, the invention is directed to the synthesis of intermediate purified diacetyl-acyclovir, the conversion of the diacetyl-acyclovir to an acyclovir-potassium salt, and the conversion of the acyclovir-potassium salt to acyclovir.

    专利号:US-10226434-B2
    优先权日:2015-01-30
    标题:Design, synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity
    发明人:RADTKE KATHERINE L; PETERS HANNAH; NEYTS JOHAN; JOCHMANS DIRK; SNIJDER ERIC J
    权利人:UNIV MARYLAND; KATHOLIEKE UNIV LEUVEN/LIEDEN UNIV MEDICAL CENTER RC LEIDEN
    摘要:The present invention is directed to compounds, methods and compositions for treating or preventing viral infections using nucleosides analogs. Specifically, the present invention provides for the design and synthesis of acyclic fleximer nucleoside analogues having increased flexibility and ability to alter their conformation structures to provide increased antiviral activity potential with the result of inhibiting several coronaviruses.

    专利号:US-5648489-A
    优先权日:1994-05-17
    标题 :Syntheses of acyclic guanine nucleosides
    发明人:CHU CHUNG K; DU JINFA; WANG CHUNGUANG
    权利人:UNIV GEORGIA
    摘要:A method is provided for the synthesis of synthesis of acyclic purine nucleosides, particularly 9-(2-hydroxy-ethoxymethyl)-guanine (acyclovir) and 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine ('DHPG') where the N2,N9-diprotected guanine is reacted with CH3C(O)OCH2O(CH2)2)OC(O)CH3 or 2-acetoxymethoxy-1,3-diacetoxypropane, respectively, in the presence of a mixture of an acid and acetic anhydride, or in the presence of an acid, where the acid can be phosphoric acid or polyphosphoric acid.

    专利号:US-6043364-A
    优先权日:1996-02-22
    标 题:Regiospecific process for synthesis of acyclic nucleosides
    发明人:KUMAR ASHOKE; SINGH DHARMENDRA; WANI MUKESH JAGANNATH; JOSHI NARENDRA SRIRAM; THOMBRE PRAVIN SAHADEV; RAWAT AJAY SINGH
    权利人:LUPIN LAB LTD
    摘要:N-7 isomer of the formula is converted into a N-9 isomer of the formula by heating a suspension of the N-7 isomer in an alkylating agent of the formula
    厦门格瑞达化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.grandachem.com
    企业联系电话:+86-592-5333280👤
    📞厦门格瑞达化工有限公司 ⚠️参考联系方式
    联系人:张小姐
    电话:+86-592-5333280

    传真:+86-592-5333231
    邮箱:silvia@grandachem.com
    通信地址: 厦门市思明区湖滨北路72号中闽大厦19楼
    邮编: 361012
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:厦门市思明区湖滨北路72号中闽大厦19楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    襄阳展达生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.extendabio.com
    企业联系电话:0710-3211378👤
    📞襄阳展达生物科技有限公司 ⚠️参考联系方式
    联系人:贺先生
    电话:0710-3211378
    手机:17786770208
    传真:0710-3529916
    邮箱:sales@extendabio.com
    通信地址: 湖北省襄阳市襄城区檀溪路恒大名都19栋(办公通讯)
    邮编: 441021
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:湖北省襄阳市襄城区檀溪路恒大名都19栋(办公通讯)
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2003).
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知